ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of tumors that lack estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), which represents 15–20% of all breast cancers [1].